Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05450965
Title Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Taofeek Owonikoko
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.